Background Cancer care represents a substantial and rapidly rising healthcare cost in
Australia. Our aim was to provide accurate population-based estimates of the health …

Abstract Aim/Background The FACT COST is a patient‐rated measure of financial toxicity,
developed and validated in a North American population. We aimed to confirm the validity …

Purpose Immune checkpoint inhibitors (ICI) and BRAF and MEK inhibitors (BMi) have
improved survival in metastatic melanoma (MM). However, the experience of long-term …

Background People with a cancer diagnosis experience physical and emotional impacts that
may affect employment. Alongside cancer care costs, reduced ability to generate an income …

Background In response to the increasing cancer prevalence and the evolving health
service landscape across the public and private health sectors in Australia, this study aimed …

In 2006, the United States Institute of Medicine published a seminal report entitled “From
cancer patient to cancer survivor: lost in transition”, 1 which articulated the unique …

Abstract Background Indigenous Australians diagnosed with cancer have poorer survival
compared to non-Indigenous Australians. We aim to: 1) identify differences by Indigenous …

Objective Sarcoma is a rare cancer that imposes a significant burden on the lives of patients.
Many survivors have long‐term disability as a result of treatment and the disease. Patients …

Medical out-of-pocket costs paid by patients can be problematic when it adversely affects
access to care. Survey research involving patients with out-of-pocket expenses may have …

Objective Prostate cancer is one of the most common male cancers in the world and
accounts for substantial morbidity, mortality, loss of disability-adjusted life-years, and …